vs
Side-by-side financial comparison of ICON PLC (ICLR) and Ovintiv Inc. (OVV). Click either name above to swap in a different company.
Ovintiv Inc. is the larger business by last-quarter revenue ($2.1B vs $2.0B, roughly 1.0× ICON PLC). Ovintiv Inc. runs the higher net margin — 46.1% vs 0.1%, a 45.9% gap on every dollar of revenue. On growth, ICON PLC posted the faster year-over-year revenue change (0.6% vs -6.0%). Ovintiv Inc. produced more free cash flow last quarter ($489.0M vs $333.9M). Over the past eight quarters, ICON PLC's revenue compounded faster (0.6% CAGR vs -7.2%).
ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.
Ovintiv Inc. is a U.S. petroleum company based in Denver. The company was formed in 2020 through a restructuring of its Canadian predecessor, Encana.
ICLR vs OVV — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $2.1B |
| Net Profit | $2.4M | $946.0M |
| Gross Margin | — | — |
| Operating Margin | 4.2% | 21.2% |
| Net Margin | 0.1% | 46.1% |
| Revenue YoY | 0.6% | -6.0% |
| Net Profit YoY | -98.8% | 1676.7% |
| EPS (diluted) | $0.03 | $3.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.1B | ||
| Q3 25 | $2.0B | $2.0B | ||
| Q2 25 | $2.0B | $2.2B | ||
| Q1 25 | $2.0B | $2.4B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $2.0B | $2.2B | ||
| Q2 24 | $2.1B | $2.2B | ||
| Q1 24 | $2.1B | $2.4B |
| Q4 25 | — | $946.0M | ||
| Q3 25 | $2.4M | $148.0M | ||
| Q2 25 | $183.0M | $307.0M | ||
| Q1 25 | $154.2M | $-159.0M | ||
| Q4 24 | — | $-60.0M | ||
| Q3 24 | $197.1M | $507.0M | ||
| Q2 24 | $146.9M | $340.0M | ||
| Q1 24 | $187.4M | $338.0M |
| Q4 25 | — | 21.2% | ||
| Q3 25 | 4.2% | 13.5% | ||
| Q2 25 | 10.4% | 23.1% | ||
| Q1 25 | 11.0% | -3.7% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 14.1% | 24.2% | ||
| Q2 24 | 10.8% | 25.4% | ||
| Q1 24 | 13.7% | 20.7% |
| Q4 25 | — | 46.1% | ||
| Q3 25 | 0.1% | 7.3% | ||
| Q2 25 | 9.1% | 13.9% | ||
| Q1 25 | 7.7% | -6.7% | ||
| Q4 24 | — | -2.7% | ||
| Q3 24 | 9.7% | 23.3% | ||
| Q2 24 | 6.9% | 15.5% | ||
| Q1 24 | 9.0% | 14.2% |
| Q4 25 | — | $3.64 | ||
| Q3 25 | $0.03 | $0.57 | ||
| Q2 25 | $2.30 | $1.18 | ||
| Q1 25 | $1.90 | $-0.61 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | $2.36 | $1.92 | ||
| Q2 24 | $1.76 | $1.27 | ||
| Q1 24 | $2.25 | $1.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $468.9M | $280.0M |
| Total DebtLower is stronger | — | $5.2B |
| Stockholders' EquityBook value | $9.3B | $11.2B |
| Total Assets | $16.5B | $20.4B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $280.0M | ||
| Q3 25 | $468.9M | $25.0M | ||
| Q2 25 | $390.4M | $20.0M | ||
| Q1 25 | $526.7M | $8.0M | ||
| Q4 24 | — | $42.0M | ||
| Q3 24 | $695.5M | $9.0M | ||
| Q2 24 | $506.6M | $8.0M | ||
| Q1 24 | $396.1M | $5.0M |
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $5.2B | ||
| Q2 25 | — | $5.3B | ||
| Q1 25 | — | $5.5B | ||
| Q4 24 | — | $5.5B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $6.1B | ||
| Q1 24 | — | $6.2B |
| Q4 25 | — | $11.2B | ||
| Q3 25 | $9.3B | $10.2B | ||
| Q2 25 | $9.6B | $10.4B | ||
| Q1 25 | $9.5B | $10.1B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | $9.8B | $10.7B | ||
| Q2 24 | $9.6B | $10.3B | ||
| Q1 24 | $9.4B | $10.3B |
| Q4 25 | — | $20.4B | ||
| Q3 25 | $16.5B | $19.4B | ||
| Q2 25 | $16.6B | $19.7B | ||
| Q1 25 | $16.7B | $19.6B | ||
| Q4 24 | — | $19.3B | ||
| Q3 24 | $17.2B | $19.9B | ||
| Q2 24 | $17.0B | $19.8B | ||
| Q1 24 | $17.0B | $19.8B |
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.55× | ||
| Q2 24 | — | 0.59× | ||
| Q1 24 | — | 0.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $387.6M | $954.0M |
| Free Cash FlowOCF − Capex | $333.9M | $489.0M |
| FCF MarginFCF / Revenue | 16.3% | 23.8% |
| Capex IntensityCapex / Revenue | 2.6% | 22.6% |
| Cash ConversionOCF / Net Profit | 164.59× | 1.01× |
| TTM Free Cash FlowTrailing 4 quarters | $1.0B | $1.5B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $954.0M | ||
| Q3 25 | $387.6M | $812.0M | ||
| Q2 25 | $146.2M | $1.0B | ||
| Q1 25 | $268.2M | $873.0M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | $402.7M | $1.0B | ||
| Q2 24 | $218.6M | $1.0B | ||
| Q1 24 | $327.1M | $659.0M |
| Q4 25 | — | $489.0M | ||
| Q3 25 | $333.9M | $268.0M | ||
| Q2 25 | $113.9M | $492.0M | ||
| Q1 25 | $239.3M | $256.0M | ||
| Q4 24 | — | $468.0M | ||
| Q3 24 | $359.3M | $484.0M | ||
| Q2 24 | $182.3M | $398.0M | ||
| Q1 24 | $299.9M | $68.0M |
| Q4 25 | — | 23.8% | ||
| Q3 25 | 16.3% | 13.3% | ||
| Q2 25 | 5.6% | 22.2% | ||
| Q1 25 | 12.0% | 10.8% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | 17.7% | 22.2% | ||
| Q2 24 | 8.6% | 18.1% | ||
| Q1 24 | 14.3% | 2.8% |
| Q4 25 | — | 22.6% | ||
| Q3 25 | 2.6% | 26.9% | ||
| Q2 25 | 1.6% | 23.5% | ||
| Q1 25 | 1.4% | 26.0% | ||
| Q4 24 | — | 25.3% | ||
| Q3 24 | 2.1% | 24.7% | ||
| Q2 24 | 1.7% | 28.4% | ||
| Q1 24 | 1.3% | 24.8% |
| Q4 25 | — | 1.01× | ||
| Q3 25 | 164.59× | 5.49× | ||
| Q2 25 | 0.80× | 3.30× | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.04× | 2.02× | ||
| Q2 24 | 1.49× | 3.00× | ||
| Q1 24 | 1.74× | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ICLR
| Other Customers | $681.3M | 33% |
| Clients1125 | $549.4M | 27% |
| Clients15 | $503.3M | 25% |
| Clients610 | $308.8M | 15% |
OVV
| Product And Service Revenue | $1.7B | 84% |
| Sales Of Purchased Product | $338.0M | 16% |
